Fig. 4.
a Epithelioid localized malignant mesothelioma. The tumor cells exhibit strong nuclear and cytoplasmic immunoreactivity for calretinin (PAP, 100×). b Epithelioid localized malignant mesothelioma. The tumor cells exhibit nuclear immunoreactivity for WT-1 (PAP, 100×)